People · Operator
Named in public records as an officer, director or promoter · active 2010–2021 · Biotechnology, Other Health Care, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Guardant Health, Inc. | — | Biotechnology | Series D+ | $500.0M | $13.2B | 2013 |
| Voyage Medical Inc | — | Other Health Care | Series B | $21.0M | $8.3M | 2010 |
| Pliant.io, Inc. | — | Software / Tech | Series A | $13.4M | $208.4M | 2021 |
| S2 Genomics, Inc. | — | Biotechnology | Seed | $4.4M | $64.6M | 2021 |
Michael Wiley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Wiley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Samir Kaul | 1 | 32 |
| Robert Davoli | 1 | 22 |
| Arman Pahlavan | 1 | 12 |
| PETER WAGNER | 1 | 11 |
| Dana G. Mead, Jr. | 1 | 7 |
| Aaref Hilaly | 1 | 6 |
| Michael Finney | 1 | 6 |
| Timothy McSweeney | 1 | 5 |
| Robert Adelson | 1 | 5 |
| Helmy Eltoukhy | 1 | 2 |
| AmirAli Talasaz | 1 | 2 |
| Warren Hogarth | 1 | 2 |
| Allan Zingeler | 1 | 2 |
| Stevan Jovanovich | 1 | 2 |
| Matthew Goldberg | 1 | 2 |
| Jeffrey G. Gold | 1 | 2 |
| Vahid Saadat | 1 | 2 |
| Vesselin Bakalov | 1 | 2 |
| Roger McIntosh | 1 | 1 |
| Dimitar Blagoev | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.